Cargando…

Will magnetic resonance imaging (MRI)-based contrast agents for molecular receptor imaging make their way into the clinic?

Detalles Bibliográficos
Autores principales:	Glunde, Kristine, Bhujwalla, Zaver M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2008
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823480/ https://www.ncbi.nlm.nih.gov/pubmed/18208557 http://dx.doi.org/10.1111/j.1582-4934.2008.00248.x

Ejemplares similares

Targeting Phospholipid Metabolism in Cancer
por: Cheng, Menglin, et al.
Publicado: (2016)

Molecular Effects of Doxorubicin on Choline Metabolism in Breast Cancer()()
por: Cheng, Menglin, et al.
Publicado: (2017)

The Tumor Microenvironment Modulates Choline and Lipid Metabolism
por: Mori, Noriko, et al.
Publicado: (2016)

Breast cancer cell adhesome and degradome interact to drive metastasis
por: Rizwan, Asif, et al.
Publicado: (2015)

Theranostics and contrast agents for magnetic resonance imaging
por: Jeong, Yohan, et al.
Publicado: (2018)

Editorial: Exploring Cancer Metabolic Reprogramming through Molecular Imaging
por: Podo, Franca, et al.
Publicado: (2017)

Use of contrast agents in oncological imaging: magnetic resonance imaging
por: Morana, Giovanni, et al.
Publicado: (2013)

Contrast agents in dynamic contrast-enhanced magnetic resonance imaging
por: Yan, Yuling, et al.
Publicado: (2017)

Dynamically switchable magnetic resonance imaging contrast agents
por: Wang, Qiyue, et al.
Publicado: (2021)

Contrast Agents of Magnetic Resonance Imaging and Future Perspective
por: Lv, Jie, et al.
Publicado: (2023)

Challenges and Initiatives in Diversity, Equity and Inclusion in Cancer Molecular Imaging
por: Daldrup-Link, Heike E., et al.
Publicado: (2021)

Estrogen Receptor-Targeted Contrast Agents for Molecular Magnetic Resonance Imaging of Breast Cancer Hormonal Status
por: Pais, Adi, et al.
Publicado: (2016)

Collagen fibers mediate MRI-detected water diffusion and anisotropy in breast cancers
por: Kakkad, Samata, et al.
Publicado: (2016)

Development of New Contrast Agents for Imaging Function and Metabolism by Magnetic Resonance Imaging
por: Carvalho, Alexandra, et al.
Publicado: (2017)

Evaluation of Microbubbles as Contrast Agents for Ultrasonography and Magnetic Resonance Imaging
por: Li, Ling, et al.
Publicado: (2012)

Activatable T(1) and T(2) Magnetic Resonance Imaging Contrast Agents
por: Tu, Chuqiao, et al.
Publicado: (2011)

Nanoparticle-Based Paramagnetic Contrast Agents for Magnetic Resonance Imaging
por: Pellico, Juan, et al.
Publicado: (2019)

Metastatic breast cancer cells in lymph nodes increase nodal collagen density
por: Rizwan, Asif, et al.
Publicado: (2015)

GRPR-targeted Protein Contrast Agents for Molecular Imaging of Receptor Expression in Cancers by MRI
por: Pu, Fan, et al.
Publicado: (2015)

Low-molecular-weight paramagnetic (19)F contrast agents for fluorine magnetic resonance imaging
por: Herynek, Vít, et al.
Publicado: (2018)

Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents
por: Estelrich, Joan, et al.
Publicado: (2015)

Surface impact on nanoparticle-based magnetic resonance imaging contrast agents
por: Zhang, Weizhong, et al.
Publicado: (2018)

Gd-Si Oxide Nanoparticles as Contrast Agents in Magnetic Resonance Imaging
por: Cabrera-García, Alejandro, et al.
Publicado: (2016)

Synthesis and Comparative Evaluation of Photoswitchable Magnetic Resonance Imaging Contrast Agents
por: Gao, Mingchun, et al.
Publicado: (2020)

Advances in magnetic resonance imaging contrast agents for glioblastoma-targeting theranostics
por: Wu, Zijun, et al.
Publicado: (2021)

Recent development of contrast agents for magnetic resonance and multimodal imaging of glioblastoma
por: Zhuang, Danping, et al.
Publicado: (2022)

A Comprehensive Introduction to Magnetic Resonance Imaging Relaxometry and Contrast Agents
por: Alzola-Aldamizetxebarria, Saioa, et al.
Publicado: (2022)

Cell sorting microbeads as novel contrast agent for magnetic resonance imaging
por: Khurana, Aman, et al.
Publicado: (2022)

Magnetic properties of biofunctionalized iron oxide nanoparticles as magnetic resonance imaging contrast agents
por: Gervits, Natalia E, et al.
Publicado: (2019)

T(1)–T(2) molecular magnetic resonance imaging of renal carcinoma cells based on nano-contrast agents
por: Li, Jingjing, et al.
Publicado: (2018)

Molecular Magnetic Resonance Imaging with Contrast Agents for Assessment of Inflammatory Bowel Disease: A Systematic Review
por: Luo, Yifan, et al.
Publicado: (2020)

Double agents and secret agents: the emerging fields of exogenous chemical exchange saturation transfer and T(2)-exchange magnetic resonance imaging contrast agents for molecular imaging
por: Daryaei, Iman, et al.
Publicado: (2015)

New Dual Mode Gadolinium Nanoparticle Contrast Agent for Magnetic Resonance Imaging
por: Ghaghada, Ketan B., et al.
Publicado: (2009)

Carbon-coated iron oxide nanoparticles as contrast agents in magnetic resonance imaging
por: Bae, Hongsub, et al.
Publicado: (2012)

Nanoparticle-Based Systems for T(1)-Weighted Magnetic Resonance Imaging Contrast Agents
por: Zhu, Derong, et al.
Publicado: (2013)

Combination of magnetic resonance imaging and targeted contrast agent for the diagnosis of myocardial infarction
por: Qin, Jiangjun, et al.
Publicado: (2018)

Methemoglobin Modulation as an Intravascular Contrast Agent for Magnetic Resonance Imaging: Proof of Concept
por: McNally, J. Scott, et al.
Publicado: (2019)

Supramolecular and biomacromolecular enhancement of metal-free magnetic resonance imaging contrast agents
por: Lee, Hamilton, et al.
Publicado: (2020)

Nitroxyl Radical as a Theranostic Contrast Agent in Magnetic Resonance Redox Imaging
por: Matsumoto, Ken-ichiro, et al.
Publicado: (2022)

Aptamer-conjugated Magnetic Nanoparticles as Targeted Magnetic Resonance Imaging Contrast Agent for Breast Cancer
por: Keshtkar, Mohammad, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_urjugg4ib70ip5qhafar8pj3gd